New drug candidate reverses metabolic liver disease and fibrosis, pre-clinical data show
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis—a dangerous, disease-induced ...
Jan 13, 2026
0
23
